Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | CDC25B | P30305 | 3/20 | 0.55 |
| ▸ | MAOA | P21397 | 5/20 | 0.52 |
| ▸ | S100A4 | P26447 | 3/20 | 0.52 |
| ▸ | APAF1 | O14727 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 2/20 | 0.52 |
| ▸ | TDP2 | O95551 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | BLM | P54132 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | TERT | O14746 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.52 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL545308 | 1.00 | MEN1 (0.55) | MEN1KMT2ACDC25BMAOAS100A4 | |
| SCHEMBL29080974 | 0.97 | CDC25B (0.52) | MEN1KMT2ACDC25BMAOAS100A4 | |
| Anthraquinone SCHEMBL11352939 | 0.97 | MEN1 (0.60) | MEN1KMT2ACDC25BMAOAS100A4 | |
| SCHEMBL10697311 | 0.97 | MEN1 (0.52) | MEN1KMT2ACDC25BMAOAS100A4 | |
| SCHEMBL10697306 | 0.97 | MEN1 (0.52) | MEN1KMT2ACDC25BMAOAS100A4 | |
| Phentydrone SCHEMBL875187 | 0.95 | MEN1 (0.57) | MEN1KMT2ACDC25BMAOAS100A4 | |
| Phentydrone SCHEMBL9628384 | 0.89 | MEN1 (0.50) | MEN1KMT2ACDC25BMAOAS100A4 | |
| SCHEMBL5802523 | 0.89 | MEN1 (0.44) | MEN1KMT2ACDC25BMAOAS100A4 | |
| Phentydrone SCHEMBL147182 | 0.87 | MEN1 (0.48) | MEN1KMT2ACDC25BMAOAS100A4 | |
| SCHEMBL23198962 | 0.84 | PTPRC (0.53) | MEN1KMT2ACDC25BS100A4APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713308-A2 | IMPROVED PRODUCTION OF REACTION PRODUCTS FROM AN ELECTROSYNTHETIC REACTION | Quino Energy, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| CN-116490270-B | Regenerated catalyst of working solution for synthesizing hydrogen peroxide | 喜星触媒株式会社 | 2025-06-10 | — | — | CN | disclosed |
| US-12296326-B2 | Catalyst for synthesis of hydrogen peroxide and recovery, and method of preparing same | HEESUNG CATALYSTS CORPORATION (KR) | 2025-05-13 | — | — | US | disclosed |
| WO-2024242934-A9 | IMPROVED PRODUCTION OF REACTION PRODUCTS FROM AN ELECTROSYNTHETIC REACTION | QUINO ENERGY, INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| WO-2024242934-A2 | IMPROVED PRODUCTION OF REACTION PRODUCTS FROM AN ELECTROSYNTHETIC REACTION | QUINO ENERGY, INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| US-20240380007-A1 | ANTHRAQUINONE COMPOUND-CONTAINING NON-AQUEOUS ELECTROLYTE SOLUTION AND SECONDARY BATTERY INCLUDING THE SAME | AIR WATER PERFORMANCE CHEMICAL INC. (JP) | 2024-11-14 | — | — | US | disclosed |
| US-20240140969-A1 | ANTHRAQUINONE-BASED COVALENT ORGANIC FRAMEWORKS | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-05-02 | — | — | US | disclosed |
| CN-117866203-A | Anthraquinone-based covalent organic frameworks | 香港科技大学 | 2024-04-12 | — | — | CN | disclosed |
| CN-112335081-B | Organic shrink-proof agent for lead accumulator | 日本制纸株式会社 | 2024-04-09 | — | — | CN | disclosed |
| US-20240001345-A1 | CATALYST FOR HYDROGEN PEROXIDE SYNTHESIS AND REGENERATION | HEESUNG CATALYSTS CORPORATION (KR) | 2024-01-04 | — | — | US | disclosed |
| CN-113950371-B | Catalyst for synthesizing hydrogen peroxide and regenerating and its preparing process | 喜星触媒株式会社 | 2023-12-29 | — | — | CN | disclosed |
| US-20230415130-A1 | CATALYST FOR REGENERATING WORKING SOLUTION FOR SYNTHESIZING HYDROGEN PEROXIDE | HEESUNG CATALYSTS CORPORATION (KR) | 2023-12-28 | — | — | US | disclosed |
| CN-116583347-A | Hydrogen peroxide synthesis and regenerated catalyst | 喜星触媒株式会社 | 2023-08-11 | — | — | CN | disclosed |
| CN-116490270-A | Regenerated catalyst of working solution for synthesizing hydrogen peroxide | 喜星触媒株式会社 | 2023-07-25 | — | — | CN | disclosed |
| WO-2023032362-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION CONTAINING ANTHRAQUINONE COMPOUND AND SECONDARY BATTERY INCLUDING SAME | エア・ウォーター・パフォーマンスケミカル株式会社 | 2023-03-09 | — | — | WO | disclosed |
| US-20220331789-A1 | CATALYST FOR SYNTHESIS OF HYDROGEN PEROXIDE AND RECOVERY, AND METHOD OF PREPARING SAME | HEESUNG CATALYSTS CORPORATION (KR) | 2022-10-20 | — | — | US | disclosed |
| CN-110891980-B | Radical polymerization control agent and radical polymerization control method | 川崎化成工业株式会社 | 2022-09-30 | — | — | CN | disclosed |
| CN-112694507-B | Tetrahydro anthraquinone glycoside compound and application thereof in preparation of antitumor drugs | 中山大学 | 2022-03-29 | — | — | CN | disclosed |
| CN-112694507-B | Tetrahydro anthraquinone glycoside compound and application thereof in preparation of antitumor drugs | 中山大学 | 2022-03-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240140969-A1 | ANTHRAQUINONE-BASED COVALENT ORGANIC FRAMEWORKS | AURKA, AQP1, AURKB | MEN1 3289/4885KMT2A 1179/4885CDC25B 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.